title: Agomelatine may improve REM sleep behavior disorder symptoms.
authors.forename: Anastasios
authors.initials: A
authors.lastname: Bonakis
authors.forename: Nicholas-Tiberio
authors.initials: NT
authors.lastname: Economou
authors.forename: Sokratis G
authors.initials: SG
authors.lastname: Papageorgiou
authors.forename: Emmanuil
authors.initials: E
authors.lastname: Vagiakis
authors.forename: Serafeim
authors.initials: S
authors.lastname: Nanas
authors.forename: Thomas
authors.initials: T
authors.lastname: Paparrigopoulos
mesh_terms: D000081:Acetamides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D020187:REM Sleep Behavior Disorder / Q000188:drug therapy* / Q000503:physiopathology; D012720:Severity of Illness Index; D016896:Treatment Outcome; D009281:Naphthalenes
chemical_list: D000081:Acetamides; D006993:Hypnotics and Sedatives; C084711:agomelatine; D009281:Naphthalenes